My son has a terminal disease — why FDA delays are failing families like mine
Summary
A mother of a 14-year-old with Duchenne muscular dystrophy says she invited FDA Commissioner Dr. Martin Makary to see the impact of delayed rare disease treatme...
Description
A mother of a 14-year-old with Duchenne muscular dystrophy says she invited FDA Commissioner Dr. Martin Makary to see the impact of delayed rare disease treatme...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source